Dr. Hajdenberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
One Main St.
Cambridge, MA 02142Phone+1 407-242-8500- Is this information wrong?
Education & Training
- Massachusetts Institute of TechnologyCertification, Drug and Medical Device Development, 2022
- Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1994 - 1997
- Cooper Medical School of Rowan University/Cooper University HospitalResidency, Internal Medicine, 1991 - 1994
- University of Buenos AiresClass of 1990
Certifications & Licensure
- NH State Medical License 1996 - Present
- MA State Medical License 1994 - 2026
- FL State Medical License 1997 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top Doctors Castle Connolly, 2016-2022
- Health Care Provider of the Year Leukemia Lymphoma Society, 2016
Publications & Presentations
PubMed
- Rucaparib or Physician's Choice in Metastatic Prostate Cancer.Fizazi K, Piulats JM, Reaume MN, Ostler P, McDermott R, Gingerich JR, Pintus E, Sridhar SS, Bambury RM, Emmenegger U, Lindberg H, Morris D, Nolè F, Staffurth J, Redfer...> ;The New England journal of medicine. 2023-02-16
- 1 citationsTemplate bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study of 148 patients--a rebuttal.J. Hajdenberg> ;Journal of Thrombosis and Haemostasis. 2004 Dec 1
- Phase 3 trial of everolimus for metastatic renal cell carcinoma : final results and analysis of prognostic factors.Motzer RJ, Escudier B, Oudard S, Hutson TE, Porta C, Bracarda S, Grünwald V, Thompson JA, Figlin RA, Hollaender N, Kay A, Ravaud A, RECORD‐1 Study Group> ;Cancer.
- Join now to see all
Press Mentions
- Reader Responses: Can I Start Cytoreductive Therapy in a Patient with Low-Risk Polycythemia Vera?December 1st, 2020
- Reader Responses: How Would You Treat This Patient with JAK2-Positive Essential Thrombocythemia?November 30th, 2020
- Reader Responses: Is Hypogammaglobulinemia Alone an Indication for Treatment for CLL?November 1st, 2020
- Join now to see all
Committees
- Member, IDEA/ASCO 2020 - 2022
- Member, Prostate Cancer Advisory Committee/State of Florida 2016 - 2021
Professional Memberships
- Member
- Member
- FLASCO: Florida Society of Clinical OncologyMember
- Massachusetts Medical SocietyMember
Other Languages
- Spanish
Hospital Affiliations
- Veterans Affairs Boston Healthcare System - Jamaica PlainJamaica Plain, Massachusetts
Industry Relationships
- Senior Medical Director, Black Diamond Therapeutics2021 - Present
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: